Blog Posts

Psychemedics + Urine Testing?

by
Psychemedics + Urine Testing? More safety sensitive businesses are adding Psychemedics to drug testing protocols. Here is why. If you are considering a Psychemedics hair test vs Urine you are in good company. For example, J.B. Hunt extended their DOT-mandated urine testing program in 2005 to include a Psychemedics hair test. A urine test is ... Read more

A Growing Epidemic Inside The Pandemic

by
CDC and DEA Cite a Growing Drug Overdose Epidemic Inside the COVID Pandemic   Record drug deaths create new and urgent challenges. Drug deaths in 2020 concern anyone who, like me, is a bit of a data geek. The most recently released CDC and DEA data paints a picture of a persistent epidemic. Beyond that, ... Read more

Cocaine and Fentanyl Don’t Discriminate When They Kill.

by
Cocaine and Fentanyl Don't Discriminate When They Kill Athlete.  Drug user.  Casualty. Cocaine and fentanyl are a deadly mix. And in the case of Jimmy Hayes, we are reminded that it has no boundaries and does not discriminate when it kills. Jimmy Hayes, by all accounts, was an All-American boy, growing up with a passion ... Read more

Counterfeit pills threat leads DEA to issue alert

by
DEA Alerts Public To Counterfeit Pill Threat Rising Supply and Rising Death Rate prompt a rare alert We are forwarding this alert regarding fentanyl because counterfeit pills-like counterfeit oxycodone pills made from it are the most urgent drug threat in the workplace today.  In fact, the data we collect suggests that we may already be ... Read more

Fentanyl Epidemic? 2021 could be the start.

by
Fentanyl epidemic?  Probably. 2020 overdose deaths give a clue. Is a fentanyl epidemic taking shape? An article from this week's New York Times paints an excellent picture of how quickly the drug ravages a community. Fentanyl deaths and overdoses are on the rise. The message is clear that fentanyl is the dominant drug threat for ... Read more

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

by
ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all of the company’s legal activities. She will report directly to the company’s CEO. Sarah rejoins Psychemedics from ... Read more

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

by
ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek had joined the Company as Vice President, Controller. In this important role, Andrew will be responsible for directing and managing all of the Company’s financial activities, including external reporting and internal analysis. He will report directly to the Company’s ... Read more

Robyn C. Davis Joins Psychemedics Board of Directors

by
ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporation effective immediately. Ms. Davis will be filling the vacancy created by the untimely passing this past December of Clint Allen, a long-time and dedicated Psychemedics ... Read more